Anal HPV infection in HIV-positive men who have sex with men from China

Lei Gao, Feng Zhou, Xiangwei Li, Yu Yang, Yuhua Ruan, Qi Jin, Lei Gao, Feng Zhou, Xiangwei Li, Yu Yang, Yuhua Ruan, Qi Jin

Abstract

Background: Anal HPV infection, which contributes to the development of anal warts and anal cancer, is well known to be common among men who have sex with men (MSM), especially among those HIV positives. However, HIV and anal HPV co-infection among MSM has not been addressed in China.

Methods: A cross-sectional study was conducted in Beijing and Tianjin, China. Study participants were recruited using multiple methods with the collaboration of local volunteer organizations. Blood and anal swabs were collected for HIV-1 serological test and HPV genotyping.

Results: A total of 602 MSM were recruited and laboratory data were available for 578 of them (96.0%). HIV and anal HPV prevalence were 8.5% and 62.1%, respectively. And 48 MSM (8.3%) were found to be co-infected. The HPV genotypes identified most frequently were HPV06 (19.6%), HPV16 (13.0%), HPV52 (8.5%) and HPV11 (7.6%). Different modes of HPV genotypes distribution were observed with respect to HIV status. A strong dose-response relationship was found between HIV seropositivity and multiplicity of HPV genotypes (p<0.001), which is consistent with the observation that anal HPV infection was an independent predictor for HIV infection.

Conclusions: A high prevalence of HIV and anal HPV co-infection was observed in the MSM community in Beijing and Tianjin, China. Anal HPV infection was found to be independently associated with increased HIV seropositivity, which suggests the application of HPV vaccine might be a potential strategy to reduce the acquisition of HIV infection though controlling the prevalence of HPV.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102:3–8.
    1. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24(Suppl 1):S1–15.
    1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–350.
    1. Shah KV. Human papillomaviruses and anogenital cancers. N Engl J Med. 1997;337:1386–1388.
    1. Palefsky JM, Holly EA, Gonzales J, Berline J, Ahn DK, et al. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res. 1991;51:1014–1019.
    1. Abbas A, Yang G, Fakih M. Management of anal cancer in 2010. Part 1: Overview, screening, and diagnosis. Oncology (Williston Park) 2010;24:364–369.
    1. Palefsky JM, Rubin M. The epidemiology of anal human papillomavirus and related neoplasia. Obstet Gynecol Clin North Am. 2009;36:187–200.
    1. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361–367.
    1. de Pokomandy A, Rouleau D, Ghattas G, Vezina S, Cote P, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis. 2009;199:965–973.
    1. Kreuter A, Wieland U. Human papillomavirus-associated diseases in HIV-infected men who have sex with men. Curr Opin Infect Dis. 2009;22:109–114.
    1. Auvert B, Lissouba P, Cutler E, Zarca K, Puren A, et al. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr. 2010;53:111–116.
    1. Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS. 2009;23:1135–1142.
    1. Smith JS, Moses S, Hudgens MG, Parker CB, Agot K, et al. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis. 2010;201:1677–1685.
    1. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915–1927.
    1. Gao L, Zhang L, Jin Q. Meta-analysis: prevalence of HIV infection and syphilis among MSM in China. Sex Transm Infect. 2009;85:354–358.
    1. van der Snoek EM, Niesters HG, Mulder PG, van Doornum GJ, Osterhaus AD, et al. Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis. 2003;30:639–644.
    1. Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, et al. Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis. 2004;190:2070–2076.
    1. Palefsky JM, Holly EA, Efirdc JT, Da Costa M, Jay N, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS. 2005;19:1407–1414.
    1. Vajdic CM, van Leeuwen MT, Jin F, Prestage G, Medley G, et al. Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect. 2009;85:330–335.
    1. Nicol AF, Fernandes AT, Grinsztejn B, Russomano F, JR ES, et al. Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection. Diagn Mol Pathol. 2005;14:39–47.
    1. Gage JR, Sandhu AK, Nihira M, Bonecini-Almeida MdG, Cristoforoni P, et al. Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression. Obstet Gynecol. 2000;96:879–885.
    1. Salit IE, Tinmouth J, Chong S, Raboud J, Diong C, et al. Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biomarkers Prev. 2009;18:1986–1992.
    1. Kim RH, Yochim JM, Kang MK, Shin KH, Christensen R, et al. HIV-1 Tat enhances replicative potential of human oral keratinocytes harboring HPV-16 genome. Int J Oncol. 2008;33:777–782.
    1. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97:577–586.
    1. Wong FY, Huang ZJ, Wang W, He N, Marzzurco J, et al. STIs and HIV among men having sex with men in China: a ticking time bomb? AIDS Educ Prev. 2009;21:430–446.
    1. Mayaud P, Gill DK, Weiss HA, Uledi E, Kopwe L, et al. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect. 2001;77:248–254.
    1. Critchlow CW, Hawes SE, Kuypers JM, Goldbaum GM, Holmes KK, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS. 1998;12:1177–1184.
    1. Palefsky JM. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol. 2000;27:471–479.
    1. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis. 2006;6:21–31.
    1. Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, et al. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda. Sex Transm Infect. 2008;84:306–311.
    1. Simatherai D, Bradshaw CS, Fairley CK, Bush M, Heley S, et al. What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect. 2009;85:148–149.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner